BiotechTube
Home/Pipeline/Fibrosis Target Program

Fibrosis Target Program

Fibrotic Diseases

PreclinicalActive

Key Facts

Indication
Fibrotic Diseases
Phase
Preclinical
Status
Active
Company
Gero

About Gero

AI‑driven, physics‑based drug discovery platform targeting the root causes of human aging.

View full company profile

Therapeutic Areas

AgingFibrosisNeurodegeneration

Other Fibrotic Diseases Drugs

DrugCompanyPhase
Hydrogel Platform - Fibrosis ModelsEctica TechnologiesDevelopment
Fibrosis Program(s)Focal BiosciencesDiscovery
TJC0545TaiwanJ PharmaceuticalsPreclinical
SRK-441Scholar Rock HoldingDiscovery
THB222Third Harmonic BioPreclinical